PRediction of Acute Coronary Syndrome in Acute Ischemic StrokE
PRAISE
1 other identifier
observational
254
1 country
28
Brief Summary
The primary goal of the PRAISE study is to develop a diagnostic algorithm that allows the prediction of acute coronary syndrome in stroke patients with elevated levels of cardiac troponin.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2018
Longer than P75 for all trials
28 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2018
CompletedFirst Posted
Study publicly available on registry
August 1, 2018
CompletedStudy Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 26, 2022
CompletedResults Posted
Study results publicly available
March 26, 2025
CompletedMarch 26, 2025
March 1, 2025
3.4 years
July 6, 2018
July 15, 2024
March 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of Myocardial Infarction
the diagnosis will be established by an independent endpoint committee
within seven days of admission to hospital
Secondary Outcomes (3)
Mortality
at one week and at three and twelve months after the initial event, at 12 months reported.
Functional Outcome
at baseline, at one week and at three and twelve months after the initial event, 12 months reported
Cardiovascular Events
at one week and at three and twelve months after the initial event, 12 months reported
Study Arms (1)
Stroke patients with elevated troponin
Patients with acute ischemic stroke (confirmed by cerebral imaging) and cardiac troponin values \> 52 ng/l or troponin values \> 14 ng/l and dynamic change \> 20% will undergo coronary angiography
Interventions
In patients eligible for participation in the study coronary angiography, echocardiography and EKG will be performed systematically.
Eligibility Criteria
consecutive patients with acute ischemic stroke admitted to the participating sites will be systematically screened for eligibility
You may qualify if:
- diagnosis of ischemic stroke based on clinical and imaging information (CT or MRI)
- diagnosis of transient ischemic attack if the initial focal neurological deficit has been examined by a neurologist and if the ABCD2-score is ≥ 4
- Elevation of high-sensitive cardiac troponins according to the rule-in/rule-out algorithm of the 2015 ESC guidelines for NSTE-ACS, i.e. highly abnormal troponin at 0 hours (\> 52ng/l if hs-cTnT, Elecsys-Assay, or \> 52ng/l, if hs-cTnI; Architect-Assay, or \> 107 ng/l, if hs-cTnI. Dimension Vista Assay) or dynamic change \> 20% of the initial value at re-test after 3 hours with at least one value above the 99th percentile of a healthy reference population
- ability to give informed consent
- onset of symptoms \< 72 hours prior to hospital admission
You may not qualify if:
- renal insufficiency (GFR \< 30 ml/min/m²)
- contraindications for coronary angiography (e.g. manifest hyperthyroidism, allergy to contrast agent)
- lesion size \> 100 ml (either on Diffusion Weighted Imaging on cMRI or on CT if CT is performed \> 24 hours after onset) or ASPECTS score \< 7 (on CT if CT is performed \< 24 hours after onset)
- Premorbid degree of dependence (mRS \> 3)
- pregnancy or breast-feeding
- limited life expectancy \< 1 year
- consent to participate in the study given \> 72 hours after hospital admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (28)
Rhön-Klinikum Campus Bad Neustadt
Bad Neustadt an der Saale, Germany
Charité-Campus Mitte
Berlin, 10117, Germany
Charité-Campus Benjamin Franklin
Berlin, 12203, Germany
Charité-Campus Virchow Klinikum
Berlin, 13353, Germany
Jüdisches Krankenhaus
Berlin, Germany
Universitätsklinikum Bonn
Bonn, Germany
Allgemeines Krankenhaus Celle
Celle, Germany
Universitätsklinikum Dresden
Dresden, Germany
Universitätsklinikum Erlangen
Erlangen, Germany
Universitätsklinikum Frankfurt
Frankfurt, Germany
Klinikum Friedrichshafen
Friedrichshafen, Germany
Klinikum Fulda
Fulda, Germany
Universitätsmedizin Göttingen
Göttingen, Germany
Universitätsklinikum Greifswald
Greifswald, Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
Universitätsklinikum Heidelberg
Heidelberg, Germany
Universitätsklinikum Jena
Jena, Germany
Universitätsklinikum Leipzig
Leipzig, Germany
Universitätsklinikum Schleswig-Holstein, Campus Lübeck
Lübeck, Germany
Universitätsklinikum Magdeburg
Magdeburg, Germany
Universitätsklinikum Mannheim
Mannheim, Germany
Universitätsklinikum der Ludwig-Maximilians-Universität München
Munich, Germany
Technische Universität München (TUM)
München, Germany
Klinikum Nürnberg Süd
Nuremberg, Germany
Klinikum Osnabrück
Osnabrück, Germany
Universitätsmedizin Rostock
Rostock, Germany
Universitätsklinikum Tübingen
Tübingen, Germany
Universitätsklinikum Ulm
Ulm, Germany
Related Publications (3)
Nolte CH, von Rennenberg R, Litmeier S, Scheitz JF, Leistner DM, Blankenberg S, Dichgans M, Katus H, Petzold GC, Pieske B, Regitz-Zagrosek V, Wegscheider K, Zeiher AM, Landmesser U, Endres M. PRediction of acute coronary syndrome in acute ischemic StrokE (PRAISE) - protocol of a prospective, multicenter trial with central reading and predefined endpoints. BMC Neurol. 2020 Aug 27;20(1):318. doi: 10.1186/s12883-020-01903-0.
PMID: 32854663BACKGROUNDNolte CH, von Rennenberg R, Litmeier S, Leistner DM, Szabo K, Baumann S, Mengel A, Michalski D, Siepmann T, Blankenberg S, Petzold GC, Dichgans M, Katus H, Pieske B, Regitz-Zagrosek V, Braemswig TB, Rangus I, Pepic A, Vettorazzi E, Zeiher AM, Scheitz JF, Wegscheider K, Landmesser U, Endres M. Type 1 Myocardial Infarction in Patients With Acute Ischemic Stroke. JAMA Neurol. 2024 Jul 1;81(7):703-711. doi: 10.1001/jamaneurol.2024.1552.
PMID: 38829625RESULTvon Rennenberg R, Litmeier S, Szabo K, Mengel A, Petersen M, Wunderlich S, Michalski D, Thomalla G, Kallmunzer B, Petzold G, Dichgans M, Siepmann T, Royl G, Ringleb PA, Nolte CH, Endres M. Cognitive performance in patients with ischemic stroke and additional myocardial injury - results from the multicenter prospective observational PRAISE study. Neurol Res Pract. 2025 Nov 4;7(1):84. doi: 10.1186/s42466-025-00446-4.
PMID: 41189028DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Christian Nolte
- Organization
- Charité-Universitätsmedizin Berlin
Study Officials
- PRINCIPAL INVESTIGATOR
Matthias Endres, Prof
Charite University, Berlin, Germany
- PRINCIPAL INVESTIGATOR
Ulf Landmesser, Prof
Charite University, Berlin, Germany
- PRINCIPAL INVESTIGATOR
Christian Nolte, Prof
Charite University, Berlin, Germany
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof Dr med. Matthias Endres
Study Record Dates
First Submitted
July 6, 2018
First Posted
August 1, 2018
Study Start
August 1, 2018
Primary Completion
December 20, 2021
Study Completion
September 26, 2022
Last Updated
March 26, 2025
Results First Posted
March 26, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share